Klin Farmakol Farm. 2010;24(1):15-18
Pneumococcal vaccines
- Praktický lékař pro děti a dorost, Jindřichův Hradec
Pneumococcal infections cause about 1.6 million deaths annually world-wide, most of which occur in infants and old people. Communityacquired
pneumonia is the most common cause of death from pneumococcal infection. Nevertheless so-called invasive pneumococcal
diseases (IPD), primarily meningitis and bacteremia with and without a focus show the highest mortality rate. Non-invasive pneumococcal
infections such as acute otitis media and acute sinusitis, although much less severe, cause a significant burden on healthcare systems
because of their high incidence. Vaccines are an important tool in the prevention of pneumococcal infections and are indicated for all
individuals at increased risk of pneumococcal infections, namely infants and young children, the elderly and individuals of all ages with
certain risk factors.
Keywords: pneumococcal diseases, pneumococcal vaccines, conjugate vaccine, polysaccharide vaccine, risk groups
Published: May 1, 2010 Show citation
References
- WHO. WHO position paper on the pneumococcal conjugate vaccine for childhood immunization. Weekly Epidemiol Rec. 2007; 82: 93-104.
- Recommendations of the Advisory Committee on Immunization Practices (ACIP), Preventing Pneumococcal Disease Among Infants and Young Children. MMRW. Recommendations and Reports. October 06, 2000/49 (RR09); 1-38. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4909a1.htm#tab8.
- Centers for Disease Control and Prevention. Pneumococcal disease. In: Atkinson W, Wolfe S, Hamborsky J, McIntyre L. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th ed. Washington, DC: Public Health Foundations; 2009.
- Kyaw MH, Rose CE Jr, Fry AM, et al. The influence of chronic illnesses on the incidence of invasive pnuemococcal disease in adults. J Infect Dis. 2005; 192: 377-386.
Go to original source... 
Go to PubMed... - Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pnuemococcal disease. Active Bacterial Core Surveillance Team. N Eng J Med. 2000; 342: 681-689. Go to original source... Go to PubMed...